Senate Democrats are demanding that President Trump release the list of the most recent Medicare-negotiated drug prices.
Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
In recent weeks, drug manufacturers have announced shortages for several medications. Becker’s compiled a list of recent drug shortages based on data from the American Society of Health-System ...
Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...
Hosted on MSN
More tariffs by Trump: Branded pharma hit with 100% duty, and the list doesn't end there
US President Donald Trump has announced a new round of tariffs, slapping a 100% duty on pharmaceutical drugs from October 1, unless companies set up manufacturing plants in the United States.
Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...
Hosted on MSN
Trump and Big Pharma at loggerheads over drug prices
President Trump's deadline for drug price concessions has come and gone. And so far the pharmaceutical industry's expanding list of commitments has included everything but what Trump really wants. Why ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback